Sandra Aliberti Selected Research

Sandra Aliberti Research Topics

4	Neoplasms (Cancer) 01/2023 - 05/2006
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2013
3	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2013
3	Leiomyosarcoma 01/2020 - 01/2013
2	Leiomyoma (Uterine Fibroids) 09/2022 - 01/2020
1	Disease Progression 01/2020
1	Pain (Aches) 12/2019
1	Neutropenia 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Lymphopenia (Lymphocytopenia) 10/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Renal Insufficiency (Renal Failure) 01/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2009
1	Autoimmune Hepatitis 12/2009
1	Hepatitis 12/2009

3	TrabectedinIBA 10/2018 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023
1	eribulin FDA Link 01/2020
1	olaparibIBA 10/2018
1	Alanine Transaminase (SGPT)IBA 10/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	liposomal doxorubicin (Doxil)FDA Link 01/2013
1	Gemcitabine FDA Link 01/2013
1	Alkylating AgentsIBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Ifosfamide FDA LinkGeneric 01/2013
1	PlatinumIBA 01/2013
1	AnthracyclinesIBA 01/2013
1	1-dodecylpyridoxal (PLD)IBA 01/2013
1	Imatinib Mesylate (Gleevec)FDA Link 12/2009

6	Therapeutics 01/2023 - 05/2006
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2013
1	Immunotherapy 01/2023
1	Morcellation 09/2022
1	Hysterectomy 01/2020
1	Activities of Daily Living (ADL) 12/2019